Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bivalirudin in peripheral interventions.

Alexandra A Maclean1, Constantino S Peña, Barry T Katzen

  • 1Department of Surgery, New York Hospital-Queens, Flushing, New York, USA.

Techniques in Vascular and Interventional Radiology
|May 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prosthetic Aortic Valve Vegetation: A Percutaneous Mechanical Aspiration Approach.

JACC. Case reports·2026
Same author

Robot-Assisted Microwave Ablations of Liver Tumors: Is This the Beginning of a Paradigm Shift?

Journal of vascular and interventional radiology : JVIR·2026
Same author

Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis.

Journal of vascular surgery·2026
Same author

In Memoriam: Plinio Rossi, 1929-2025.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Predicting Tumor Recurrence with Early 18F-FDG PET-CT After Thermal and Non-Thermal Ablation.

Current oncology (Toronto, Ont.)·2025
Same author

The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2025
Same journal

Treatment of Coagulopathy.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Kidney Injury for the Interventional Radiologist: A Review.

Techniques in vascular and interventional radiology·2026
Same journal

Acute Management of Dysrhythmias.

Techniques in vascular and interventional radiology·2026
Same journal

An Approach to Airway Management and Acute Respiratory Failure.

Techniques in vascular and interventional radiology·2026
Same journal

Emergency Preparedness in the Vascular and Interventional Radiology Suite-An Overview.

Techniques in vascular and interventional radiology·2026
Same journal

Management of Acute Hemorrhage and Damage-Control Resuscitation: Critical Care Concepts for Vascular Interventional Radiologists.

Techniques in vascular and interventional radiology·2026
See all related articles

Bivalirudin offers a safer alternative to heparin for anticoagulation in peripheral interventions, reducing bleeding and thrombosis risks. This review details its use, dosing, and monitoring in these procedures.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Surgery
  • Pharmacology

Background:

  • Heparin is widely used in cardiac and vascular medicine but carries risks like bleeding and heparin-induced thrombocytopenia.
  • Direct thrombin inhibitors, such as bivalirudin, have emerged as favorable alternatives.
  • Bivalirudin use is expanding from coronary to peripheral interventions.

Purpose of the Study:

  • To review the use of bivalirudin as a sole anticoagulant in peripheral interventions.
  • To emphasize practical aspects of bivalirudin dosing and monitoring.
  • To discuss existing clinical trial findings on bivalirudin in peripheral interventions.

Main Methods:

  • Review of institutional experience with bivalirudin in peripheral interventions.
  • Analysis of current clinical trial data regarding bivalirudin efficacy and safety.

Related Experiment Videos

  • Description of specific dosing and monitoring protocols.

    • Main Results:

    • Bivalirudin demonstrates favorable outcomes in peripheral interventions.
    • Specific dosing and monitoring strategies can optimize bivalirudin use.
    • Clinical trials support bivalirudin's role in reducing heparin-related complications.

    Conclusions:

    • Bivalirudin is a viable and potentially safer anticoagulant for peripheral interventions compared to heparin.
    • Careful dosing and monitoring are essential for effective bivalirudin therapy.
    • Further research and clinical adoption are warranted for bivalirudin in this setting.